Absci Leveraging Gen AI for Best-in-Class Antibodies

from Vanguards of Health Care by Bloomberg Intelligence · host Bloomberg

“As US biotech companies, how do we continue to differentiate and create novel breakthrough assets? I think it’s leveraging AI,” said Sean McClain, founder and CEO of Absci. McClain and Christian Stegmann, senior vice president of drug creation, sit down with Bloomberg Intelligence analyst Andrew Galler in this episode of the Vanguards of Health Care podcast to discuss Absci’s generative AI platform and developing best-in-class biologics.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Feb 27, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Absci Leveraging Gen AI for Best-in-Class Antibodies

0:00 58:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Vanguards of Health Care by Bloomberg Intelligence?

This episode is 58 minutes long.

When was this Vanguards of Health Care by Bloomberg Intelligence episode published?

This episode was published on February 27, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Vanguards of Health Care by Bloomberg Intelligence episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!